Socialpost

Complete News World

Marinomed is shortlisted for the European SME Awards

Marinomed is shortlisted for the European SME Awards

22.09.2021

Marinomed is one of twelve companies shortlisted for the European SME Awards for 2021. The awards, initiated by European Exporters, FESE and the European Commission, will be presented on October 16 in Slovenia. Marinomed was nominated in the “Innovation Star” category. This category celebrates mediums that are still recently listed and puts innovation at the heart of their business development. The other two competitors in this category are CY4GATE, listed in Italy, and Nanoform (Finland), listed on Nasdaq. Awards are presented in four categories.

In a Q&A, Marinomed said in response to a question about the greater benefits of the IPO: “Today the company has much greater visibility for both clients and investors. The stock option program allows employees to share in the success and the individual can now access the public equity and debt markets.”

Marinomed also has advice ready for those companies that are also looking to go public: “At the beginning of an IPO project, the challenges seem endless. First, develop your own stock story. Why go public and why should investors buy their shares? Plans for the process And get good advisors. It will be a once in a lifetime experience.”



photo credit

1. Marinomed Biotech IPO, (© Wiener Börse AG / APA-Fotoservice / Hörmandinger Photographer: Martin Hörmandinger or Richard Tanzer) >> Open on photaq.com

Stocks on the radar:BiotechnologyAnd FACCAnd ZumtobelAnd Kapsch TrafficComAnd WeinerburgerAnd faceAnd Erste . groupAnd frequentAnd MARINOMED BIOTECHAnd SBOAnd compoundAnd Adiko . BankAnd pornographicAnd Meyer MilenhofAnd FrauenthalAnd Clean Energy.

See also  SoftBank and Alteros launch the world's first self-driving aircraft

random partner

UBM
UBM focuses on real estate development and covers the entire value chain from rededication and building permits to planning, marketing and construction management to sales. The focus is on the Austrian, German and Polish markets as well as on the residential, hotel and office asset classes.

>> Visit 65 other partners boerse-social.com/partner



Marinomed Biotech IPO, (© Wiener Börse AG / APA-Fotoservice / Hörmandinger Photographer: Martin Hörmandinger and Richard Tanzer)

author

Kristen Petzwinkler

Network / Borse social magazine